One-carbon therapeutics wins ELAVITY Pitch Event

by admin
juni 28, 2022

Our team is happy and proud to have been voted as the winner for pitching our MTHFD1/2 inhibitor program.

https://www.linkedin.com/feed/update/urn:li:activity:6948268990171365376

Rekommenderade artiklar

Detailed mode of action of the MTHFD1/2 inhibitor TH9619 now published in Nature Metabolism

The One-carbon Therapeutics team is proud and excited to share

We are presenting our novel MTHFD1/2 inhibitor at the DDR inhibitor summit

We are presenting our data at the DDR inhibitor summit,

One-carbon Therapeutics receives US patent

We are happy to announce that on the 22nd of

Menu bar